GSK’s Cervical Cancer Vaccine Induces Antibodies To Target Cervical Cancer Where It Starts
Nov 7th 2007Drug InformationCervical Cancer
Two years after the first of three doses, antibodies against the two most common cervical cancer-causing virus types, induced by a vaccine, have been found where they are needed, in the cervix, according to new data presented at the International Papillomavirus Conference (IPC) in Beijing. [click link for full article]
More: continued here
No Comments »
Leave a Reply
You must be logged in to post a comment.
